miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements
- PMID: 19748357
- PMCID: PMC2757794
- DOI: 10.1016/j.molcel.2009.08.020
miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements
Abstract
miR-24, upregulated during terminal differentiation of multiple lineages, inhibits cell-cycle progression. Antagonizing miR-24 restores postmitotic cell proliferation and enhances fibroblast proliferation, whereas overexpressing miR-24 increases the G1 compartment. The 248 mRNAs downregulated upon miR-24 overexpression are highly enriched for DNA repair and cell-cycle regulatory genes that form a direct interaction network with prominent nodes at genes that enhance (MYC, E2F2, CCNB1, and CDC2) or inhibit (p27Kip1 and VHL) cell-cycle progression. miR-24 directly regulates MYC and E2F2 and some genes that they transactivate. Enhanced proliferation from antagonizing miR-24 is abrogated by knocking down E2F2, but not MYC, and cell proliferation, inhibited by miR-24 overexpression, is rescued by miR-24-insensitive E2F2. Therefore, E2F2 is a critical miR-24 target. The E2F2 3'UTR lacks a predicted miR-24 recognition element. In fact, miR-24 regulates expression of E2F2, MYC, AURKB, CCNA2, CDC2, CDK4, and FEN1 by recognizing seedless but highly complementary sequences.
Figures
Similar articles
-
MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.Mol Med Rep. 2015 Jul;12(1):1016-22. doi: 10.3892/mmr.2015.3516. Epub 2015 Mar 19. Mol Med Rep. 2015. PMID: 25816091 Free PMC article.
-
miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.FEBS Lett. 2012 Nov 2;586(21):3831-9. doi: 10.1016/j.febslet.2012.08.023. Epub 2012 Sep 18. FEBS Lett. 2012. PMID: 22999819
-
Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.Oncotarget. 2016 Jun 14;7(24):36577-36589. doi: 10.18632/oncotarget.9288. Oncotarget. 2016. PMID: 27174918 Free PMC article.
-
The role of E2F2 in cancer progression and its value as a therapeutic target.Front Immunol. 2024 May 14;15:1397303. doi: 10.3389/fimmu.2024.1397303. eCollection 2024. Front Immunol. 2024. PMID: 38807594 Free PMC article. Review.
-
The E2F transcription factor 2: What do we know?Biosci Trends. 2021 May 11;15(2):83-92. doi: 10.5582/bst.2021.01072. Epub 2021 Apr 29. Biosci Trends. 2021. PMID: 33952804 Review.
Cited by
-
miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis.Development. 2012 Jan;139(1):191-202. doi: 10.1242/dev.070151. Epub 2011 Nov 24. Development. 2012. PMID: 22115756 Free PMC article.
-
Cooperative target mRNA destabilization and translation inhibition by miR-58 microRNA family in C. elegans.Genome Res. 2015 Nov;25(11):1680-91. doi: 10.1101/gr.183160.114. Epub 2015 Jul 31. Genome Res. 2015. PMID: 26232411 Free PMC article.
-
Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.J Oncol. 2015;2015:198967. doi: 10.1155/2015/198967. Epub 2015 Mar 25. J Oncol. 2015. PMID: 25883651 Free PMC article. Review.
-
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.PLoS One. 2013 May 21;8(5):e63563. doi: 10.1371/journal.pone.0063563. Print 2013. PLoS One. 2013. PMID: 23704919 Free PMC article.
-
A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.PLoS One. 2012;7(2):e31021. doi: 10.1371/journal.pone.0031021. Epub 2012 Feb 2. PLoS One. 2012. PMID: 22319602 Free PMC article.
References
-
- Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci. 2004;29:409–417. - PubMed
-
- Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353:1793–1801. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous